[Federal Register Volume 69, Number 42 (Wednesday, March 3, 2004)]
[Notices]
[Page 10053]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-4637]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke; Notice 
of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the Muscular Dystrophy Coordinating Committee.
    the meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should inform the contact person listed below in 
advance of the meeting.

    Name of Committee: Muscular Dystrophy Coordinating Committee.
    Date: March 22, 2004.
    Time: 8:30 a.m. to 4 p.m.
    Agenda: The Muscular Dystrophy Coordinating Committee (MDCC) is 
mandated by the MD-CARE Act to ``develop a plan for conducting and 
supporting research and education on muscular dystrophy through the 
national research institutes.'' The purpose of this meeting is to 
review and discuss a draft muscular dystrophy research and education 
plan for NIH.
    Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, 
Bethesda, Maryland 20817.
    Contact Person: Lorraine Fitzsimmons, Executive Secretary, 
Muscular Dystrophy Coordinating Committee, Director, Office of 
Science Policy and Planning, National Institute of Neurological 
Disorders and Stroke, NIH, 31 Center Drive, Room 8A023, MSC 2540, 
Bethesda, MD 20892, E-mail: [email protected], Phone: (301) 
496-9271.
    Any member of the public interested in presenting oral comments 
to the committee may notify the Contact Person listed on this notice 
at least 10 days in advance of the meeting. Interested individuals 
and representatives of organizations may submit a letter of intent, 
a brief description of the organization represented, and a short 
description of the oral presentation. Only one representative of an 
organization may be allowed to present oral comments and if accepted 
by the committee, presentations may be limited to five minutes. Both 
printed and electronic copies are requested for the record. In 
addition, any interested person may file written comments with the 
committee by forwarding their statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, 
Clinical Research Related to Neurological Disorders; 93.854, 
Biological Basis Research in the Neurosciences, National Institutes 
of Health, HHS).

    Dated: February 25, 2004.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 04-4637 Filed 3-2-04; 8:45 am]
BILLING CODE 4140-01-M